NanoViricides, Inc.

NNVC ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › Cash Flow Statement
Annual Quarterly

Cash Flow Statement

Line Item FY2010
Operating Activities
Net Income $-4.7M
Depreciation & Amortization —
Depreciation $82.8K
Amortization —
Stock-Based Compensation —
Net Cash from Operating Activities $-2.0M
Investing Activities
Capital Expenditures $561.3K
Business Acquisitions —
Net Cash from Investing Activities $-744.8K
Financing Activities
Dividends Paid —
Stock Repurchases —
Net Cash from Financing Activities $8.1M
Net Change in Cash $5.3M
Free Cash Flow $-2.6M
← Newer Page 3 of 3 Older →